Spironolactone Suspension
Product Images NDC 69238-2027
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 69238-2027). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Spironolactone Oral Suspension 2)
This text provides information about a survival study in RALES (Racial and Ethnic Approaches to Community Health). The study compares the treatment group that received Spirorolactone (totaling 822 patients) to the placebo group (totaling 841 patients). The study shows a significant difference in survival between the two groups, as indicated by the Log-rank p-value of less than 0.001. The time period of the study is displayed in months, ranging from 6 to 42.*
118 mL Bottle Label (Spironolactone Oral Suspension 3)
This text appears to be a description of a medication called Spironolactone. It contains 5 mg of Spironolactone per 1 mL. The usual dosage instructions should be found in the package insert. The medication should be stored at a temperature between 20 to 25 degrees Celsius (68 to 77 degrees Fahrenheit), with some flexibility between 15 to 30 degrees Celsius (59 to 86 degrees Fahrenheit). It should be dispensed in a tightly sealed container as per the USP (United States Pharmacopeia) standards. The medication should be kept out of reach of children. It is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. The specific lot number and expiration date appear to be located within a non-varnish area of the packaging.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.